We’re excited to announce that Avance Biosciences™ will be exhibiting at BioProcess International 2025, taking place September 15–18 in Boston, MA. As one of the industry’s leading events, BPI brings together scientists, engineers, and decision-makers driving innovation across biologics development, cell and gene therapy, and biomanufacturing.
In today’s evolving therapeutic landscape—spanning monoclonal antibodies, viral vectors, RNA-based therapeutics, and advanced cell therapies—robust, regulatory-compliant analytical support is more vital than ever. At Avance Biosciences, we specialize in custom assay development, method validation, and comprehensive testing services to support biopharmaceutical programs at every stage—from preclinical through commercialization.
Our capabilities include:
- Viral vector and plasmid release testing
- Host cell DNA and protein impurity analysis
- Stability and comparability studies
- Next-generation sequencing (NGS) for integration site analysis, off-target detection, and long-read sequencing
With over a decade of experience supporting IND, BLA, and global regulatory submissions, we’re proud to be a trusted partner for biopharma innovators navigating complex regulatory landscapes.
Visit us at Booth #1508 to connect with our team, explore our latest analytical solutions, and discover how Avance can help accelerate your bioprocessing, quality control, and regulatory milestones.
See you at BioProcessing Summit 2025!
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
